HealthQuill Uncategorized
Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a drug-induced liver injury that was resolved after discontinuation of the oral drug.
Uncategorized

Pfizer stops development of an investigational drug to treat obesity

HQ Team April 15, 2025: Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a.

Read More
Sonia Vallabh, a graduate of Harvard Law School and her husband  Eric Minikel, who holds a planning degree from MIT, re-engineered their careers to do research into prion disease when she was diagnosed with the disorder. Now their research may lead to a treatment if not a cure in the not-too-distant future, according to a statement from Harvard.
Uncategorized

Patient-scientist behind new gene-editing tool for prion disease

HQ Team April 10, 2025:  Sonia Vallabh, a graduate of Harvard Law School and her husband  Eric Minikel, who holds a planning degree.

Read More
Scientists have converted cancer cells to healthy ones to treat a devastating pediatric cancer through a method called differentiation therapy.
Uncategorized

Scientists discover key protein AP2A1 that reverses cellular aging

HQ Team   February 20, 2025 – Researchers from Osaka University have identified a protein, AP2A1, that could hold the key to reversing.

Read More
Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for adult and pediatric heart patients, according to a statement.
Uncategorized

US scientists make heart valves to aid tissue regeneration, avoid surgeries

Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for.

Read More
Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion to expand its cardiovascular pipeline.
Uncategorized

Switzerland’s Novartis to buy US-based Anthos for $3.1 billion

Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion.

Read More
Billionaire Gautam Adani’s family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of Mumbai and Ahmedabad in association with Mayo Clinic Global Consulting, according to a statement.
Uncategorized

Indian billionaire Adani to invest $686.2m to build 2 health campuses

Billionaire Gautam Adani’s family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of.

Read More
Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity that may lead to novel therapies.
Uncategorized

New obesity, diabetic cures may emerge as scientists unveil brain atlas 

Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity.

Read More
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.
Uncategorized

EU panel gives a positive opinion for AstraZeneca’s cancer drug

AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish.

Read More
The US Food and Drug Administration has approved Johnson & Johnson’s nasal spray in adults who have had an inadequate response to at least two oral antidepressants for treating major depressive disorder.
Uncategorized

J&J’s nasal spray to treat major depressive disorder gets FDA nod

The US Food and Drug Administration has approved Johnson & Johnson’s nasal spray in adults who have had an inadequate response to at.

Read More
About 61.8 million globally, or one in every 127 people, had autism spectrum disorder in 2021, according to new research that expanded on the Global Disease Burden study.
Uncategorized

One in 127 people globally have autism spectrum disorder: Study

About 61.8 million globally, or one in every 127 people, had autism spectrum disorder in 2021, according to new research that expanded on.

Read More